Annual Review
Kevin Lobo Chairman and CEO

Message from our Chairman and CEO

We had an excellent year in 2019, as we reached 40 consecutive years of sales growth  


When the breast cancer surgeon becomes the patient, expertise, emotions and empathy come together

Oncoplastic surgeon Dr. Anne Peled shares her journey as both a breast cancer surgeon and patient

SPY Fluorescence: improving visualization in breast reconstruction

With an aggressive form of breast cancer, Barbara Pink chooses bilateral mastectomy and bilateral breast reconstruction

Innovation and acquisitions

Adding innovative and complementary products to our portfolio to strengthen our market leadership

Growth and globalization

Medical education programs across our portfolios are designed to help improve patient outcomes


Learn more about our 2019 financial highlights

Corporate responsibility

Our commitment to people and the planet

People and culture

Creating and investing in programs that foster a positive workplace experience


Meet our management team and board of directors

Global recognition

FORTUNE Best Workplaces (U.S.)

For Diversity, 2019
#1 out of 100 companies — recipient for the third consecutive year

For Women, 2019
#47 — recipient for the third time

FORTUNE World’s Most Admired Companies

#5 in 2020
Medical Products and Equipment — recipient for the 18th consecutive year

FORTUNE World’s Best Workplaces

#8 in 2019
out of 25 companies — recipient for the third time

FORTUNE 500 Largest U.S.-Based Companies

#233 in 2019
joined the list in 2003 — recipient for the 17th consecutive year